Bank of America’s Cumberland Pharmaceuticals CPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-9
| Closed | -$36 | – | 5970 |
|
|
2025
Q4 | $36 | Sell |
9
-8
| -47% | -$24 | ﹤0.01% | 7009 |
|
|
2025
Q3 | $53 | Sell |
17
-77
| -82% | -$256 | ﹤0.01% | 7992 |
|
|
2025
Q2 | $315 | Buy |
94
+26
| +38% | +$123 | ﹤0.01% | 7756 |
|
|
2025
Q1 | $288 | Buy |
68
+3
| +5% | +$12 | ﹤0.01% | 7617 |
|
|
2024
Q4 | $154 | Sell |
65
-74
| -53% | -$109 | ﹤0.01% | 7650 |
|
|
2024
Q3 | $178 | Buy |
139
+72
| +107% | +$100 | ﹤0.01% | 7599 |
|
|
2024
Q2 | $103 | Buy |
+67
| New | +$105 | ﹤0.01% | 7690 |
|
|
2024
Q1 | – | Sell |
-5
| Closed | -$9 | – | 7798 |
|
|
2023
Q4 | $9 | Buy |
+5
| New | +$9 | ﹤0.01% | 7789 |
|
|
2023
Q1 | – | Sell |
-9
| Closed | -$20 | – | 7866 |
|
|
2022
Q4 | $20 | Buy |
+9
| New | +$21 | ﹤0.01% | 7984 |
|
|
2022
Q3 | – | Sell |
-579
| Closed | -$1K | – | 7883 |
|
|
2022
Q2 | $1K | Buy |
579
+475
| +457% | +$1.1K | ﹤0.01% | 7853 |
|
|
2022
Q1 | $0 | Sell |
104
-20
| -16% | -$67 | ﹤0.01% | 8320 |
|
|
2021
Q4 | $0 | Buy |
124
+20
| +19% | +$68 | ﹤0.01% | 8266 |
|
|
2021
Q3 | $0 | Sell |
104
-74
| -42% | -$220 | ﹤0.01% | 8137 |
|
|
2021
Q2 | $0 | Sell |
178
-2,570
| -94% | -$7.56K | ﹤0.01% | 7791 |
|
|
2021
Q1 | $8K | Buy |
+2,748
| New | +$8.93K | ﹤0.01% | 7052 |
|
|
2020
Q3 | – | Sell |
-1,755
| Closed | -$6K | – | 6924 |
|
|
2020
Q2 | $6K | Buy |
+1,755
| New | +$6.38K | ﹤0.01% | 6529 |
|
|
2020
Q1 | – | Sell |
-154
| Closed | -$1K | – | 6898 |
|
|
2019
Q4 | $1K | Sell |
154
-316
| -67% | -$1.67K | ﹤0.01% | 6952 |
|
|
2019
Q3 | $3K | Buy |
+470
| New | +$2.61K | ﹤0.01% | 6924 |
|
|
2019
Q1 | – | Sell |
-29
| Closed | – | – | 7144 |
|
|
2018
Q4 | $0 | Sell |
29
-628
| -96% | -$3.76K | ﹤0.01% | 7143 |
|
|
2018
Q3 | $4K | Buy |
657
+648
| +7,200% | +$3.82K | ﹤0.01% | 6866 |
|
|
2018
Q2 | $0 | Buy |
+9
| New | +$56 | ﹤0.01% | 7106 |
|
|
2017
Q4 | – | Sell |
-89
| Closed | -$1K | – | 7048 |
|
|
2017
Q3 | $1K | Buy |
+89
| New | +$615 | ﹤0.01% | 6916 |
|
|
2017
Q1 | – | Sell |
-2
| Closed | – | – | 7001 |
|
|
2016
Q4 | $0 | Buy |
+2
| New | +$10 | ﹤0.01% | 7072 |
|
|
2016
Q3 | – | Sell |
-49
| Closed | – | – | 7130 |
|
|
2016
Q2 | $0 | Buy |
+49
| New | +$224 | ﹤0.01% | 7153 |
|
|
2014
Q4 | – | Sell |
-88
| Closed | – | – | 7705 |
|
|
2014
Q3 | $0 | Buy |
+88
| New | +$426 | ﹤0.01% | 8017 |
|
|
2014
Q1 | – | Sell |
-20
| Closed | – | – | 7819 |
|
|
2013
Q4 | $0 | Sell |
20
-880
| -98% | -$4.3K | ﹤0.01% | 7910 |
|
|
2013
Q3 | $4K | Sell |
900
-25,649
| -97% | -$128K | ﹤0.01% | 7449 |
|
|
2013
Q2 | $136K | Buy |
+26,549
| New | +$132K | ﹤0.01% | 5954 |
|
Other funds holding CPIX
IC
VCM
PA
BCM
BFM
JGC
Bank of America's CPIX Position: Q1 2026 in Review
Bank of America sold out of Cumberland Pharmaceuticals (CPIX) in Q1 2026, closing a stake of 9 shares — an estimated $36 sold.
Bank of America first reported a position in CPIX in Q2 2013 and held it in 28 quarters. The position peaked at $136K in Q2 2013. 29 funds tracked by Wall St. Rank hold CPIX as of Q1 2026.
- Bank of America reported no remaining Cumberland Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- Bank of America sold 9 Cumberland Pharmaceuticals shares in Q1 2026, an estimated $36.
- Bank of America first reported a position in Cumberland Pharmaceuticals in Q2 2013 and held it in 28 quarters.
- Bank of America's Cumberland Pharmaceuticals position peaked at $136K in Q2 2013.
- 29 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.